CUV.AX
Price:
$11.54
Market Cap:
$577.70M
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a c...[Read more]
Industry
Biotechnology
IPO Date
2001-02-11
Stock Exchange
ASX
Ticker
CUV.AX
According to Clinuvel Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 394.71M. This represents a change of -49.79% compared to the average of 786.08M of the last 4 quarters.
The mean historical Enterprise Value of Clinuvel Pharmaceuticals Limited over the last ten years is 749.57M. The current 394.71M Enterprise Value has changed 5.17% with respect to the historical average. Over the past ten years (40 quarters), CUV.AX's Enterprise Value was at its highest in in the June 2019 quarter at 1.54B. The Enterprise Value was at its lowest in in the March 2009 quarter at 0.
Average
749.57M
Median
642.78M
Minimum
112.61M
Maximum
1.54B
Discovering the peaks and valleys of Clinuvel Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 213.91%
Maximum Annual Enterprise Value = 1.54B
Minimum Annual Increase = -52.22%
Minimum Annual Enterprise Value = 112.61M
Year | Enterprise Value | Change |
---|---|---|
2024 | 577.98M | -32.84% |
2023 | 860.59M | 21.62% |
2022 | 707.59M | -52.22% |
2021 | 1.48B | 19.52% |
2020 | 1.24B | -19.35% |
2019 | 1.54B | 213.91% |
2018 | 489.45M | 58.41% |
2017 | 308.99M | 69.97% |
2016 | 181.79M | 61.44% |
2015 | 112.61M | 120.11% |
The current Enterprise Value of Clinuvel Pharmaceuticals Limited (CUV.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
715.39M
5-year avg
973.28M
10-year avg
749.57M
Clinuvel Pharmaceuticals Limited’s Enterprise Value is less than Pro Medicus Limited (27.99B), less than Nanosonics Limited (823.79M), less than PolyNovo Limited (1.41B), less than Fisher & Paykel Healthcare Corporation Limited (22.33B), greater than AVITA Medical, Inc. (212.87M),
Company | Enterprise Value | Market cap |
---|---|---|
27.99B | $28.05B | |
823.79M | $944.03M | |
1.41B | $1.44B | |
22.33B | $20.10B | |
212.87M | $380.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clinuvel Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Clinuvel Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Clinuvel Pharmaceuticals Limited's Enterprise Value?
What is the highest Enterprise Value for Clinuvel Pharmaceuticals Limited (CUV.AX)?
What is the 3-year average Enterprise Value for Clinuvel Pharmaceuticals Limited (CUV.AX)?
What is the 5-year average Enterprise Value for Clinuvel Pharmaceuticals Limited (CUV.AX)?
How does the current Enterprise Value for Clinuvel Pharmaceuticals Limited (CUV.AX) compare to its historical average?